NCT00052507View on ClinicalTrials.gov

Bortezomib in Treating Patients With Metastatic or Recurrent Colorectal Cancer

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

January 31, 2003

Primary Completion Date

August 31, 2005

Conditions
Colorectal Cancer
Interventions
DRUG

bortezomib

Trial Locations (4)

L8V 5C2

Cancer Care Ontario-Hamilton Regional Cancer Centre, Hamilton

N6A 4L6

Cancer Care Ontario-London Regional Cancer Centre, London

K1H 1C4

Ottawa Regional Cancer Centre, Ottawa

M5G 2M9

Princess Margaret Hospital at University Health Network, Toronto

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University Health Network, Toronto

OTHER

NCT00052507 - Bortezomib in Treating Patients With Metastatic or Recurrent Colorectal Cancer | Biotech Hunter | Biotech Hunter